- Home
- A-Z Publications
- Current Drug Research Reviews
- Previous Issues
- Volume 16, Issue 1, 2024
Current Drug Research Reviews - Volume 16, Issue 1, 2024
Volume 16, Issue 1, 2024
-
-
Is Daclatasvir a Suitable Substitute for Amphotericin B in the Treatment of Mucormycosis when Amphotericin B is Scarce?
Background: Mucormycosis has been infesting the universe for a while back, often with no prompt treatments. The disease devastation is spreading at an alarming rate. Many researchers are still hoping for a good potential drug that could help the healthcare system in this tussle. Molecular docking is an in silico tool that has gained popularity over the last few decades. Knowing the mechanism of enzymatic action is aided by Read More
-
-
-
Tegoprazan as a New Remedy for Gastrointestinal Diseases in Comparison with its Therapeutic Predecessors: A Mini-Review
Authors: Asif H. Anik, Farhana Alam Proma, Pranoy Saha and Sabarni SarkerPotassium-competitive acid blockers (P-CABs), such as tegoprazan, are a new and diverse class of drugs that can completely block the potassium-binding site of gastric H+/K+ ATPase, potentially overcoming the limitations of proton-pump inhibitors (PPIs). A number of studies have compared the effectiveness as well as the safety profile of tegoprazan to PPIs and other P-CABs for the treatment of gastrointestinal diseases. The Read More
-
-
-
Biological Importance, Pharmacological Activities, and Nutraceutical Potential of Capsanthin: A Review of Capsicum Plant Capsaicinoids
Authors: Kanika Patel and Dinesh K. PatelBackground: Carotenoids are natural hydrocarbons that play an important role in photomorphogenesis, photosynthesis, photoprotection, development, and defense mechanism of plants. Carotenoids have good anti-oxidants and provitamin A contents with their additional colorant nature, which are indispensable to plants and human diets. Capsicum species are well known for their culinary uses worldwide; they are Read More
-
-
-
Odevixibat: A Review of a Bioactive Compound for the Treatment of Pruritus Approved by the FDA
Authors: Mayur Porwal, Arvind Kumar, Vaibhav Rastogi, Kamal K. Maheshwari and Anurag VermaOdevixibat is synthesized through chemical modification of Benzothiazepine's structure. It is a tiny chemical that inhibits the ileal bile acid transporter and is used to treat a variety of cholestatic illnesses, including progressive familial intrahepatic cholestasis (PFIC). For cholestatic pruritus and liver disease development, bile acid transporter inhibition is a unique treatment strategy. Odevixibat reduces enteric bile aci Read More
-
-
-
Preclinical Evidence-based Neuroprotective Potential of Silibinin
Authors: Niraj K. Singh and Bharat BhushanNeurodegeneration is an elucidating feature of many neuronal disorders including Alzheimer’s, disease, Parkinson’s disease, and cerebral ischemia. These neurodegenerative disorders are a major public health concern with high mortality and morbidity rates around the world. Presently, researchers have concentrated their efforts on determining the neuroprotective activity of natural products for the management of neu Read More
-
-
-
Signaling Pathways and Molecular Process of Natural Polyphenols in the Amelioration of Inflammatory Bowel Disease: A Privileged Scaffold in New Drug Discovery
Authors: Om Prakash, Ruchi Singh, Priyanka Bajpai and Meera KumariGIT is seriously affected by inflammatory bowel disease (IBD), which is characterized by extreme inflammation and an imbalance in a person's healthy life span. The frequency of occurrence of such chronic diseases as IBD would continue to increase. In the past decade, increasing attention has been paid to polyphenols from natural sources have been shown to serve as successful therapeutic agents for altering the signalling Read More
-
-
-
Development and Validation of RP-HPLC Method for the Estimation of Tenofovir and Emtricitabine in Bulk and Pharmaceutical Dosage Form
Authors: Biswa M. Sahoo, Pallepogu Venkateswara Rao and Naidu Srinivasa RaoBackground: A novel, simple, efficient, rapid, and precise reverse-phase highperformance liquid chromatography (RP-HPLC) method was developed for the estimation of Tenofovir and Emtricitabine in the bulk and pharmaceutical dosage form. The currently developed method was subsequently validated according to ICH guidelines in terms of linearity, accuracy, precision, the limit of detection, the limit of quantification, robustne Read More
-
Most Read This Month
Article
content/journals/cdrr
Journal
10
5
false
en
